Latest News

Ex-head of Europe’s drug regulator set up consultancy while still in office
Following correspondence with Dr Lönngren, our press statement of 19 December 2011 has now been amended and the revised statement is available here.
2012/01/27
Open letter to and response from Health Commissionner Mr Dalli regarding new details revolving door case former head of EMA Mr Lönngren
Following correspondence with Dr Lönngren our press statement of 19 Dec 2011 has been updated. Evidence suggests Dr Lönngren’s post employment activities with private pharmaceutical industry were arranged whilst being employed by EMA. His consultancy, Pharma Executive Consulting Ltd, was incorporated 2 months before he left EMA.
2012/02/08
Open letter to and response from European Medicines Agency director: Staff Regulations ought to be reviewed and tightened
Following correspondence with Dr Lönngren, our press statement of 19 December 2011 has now been amended and is available on ALTER-EU's website and via the link in this letter. Questions regarding the application of the Staff Regulations concerning employees who take part in an outside activity, intend to leave or leave the service at the EMA.
2012/01/08
ALTER-EU Newsletter - 6 - ALTER-EU assembly (+video), 'Revolving Door' campaign launch, introduction IEMFA
Includes news regaring the ALTER-EU assembly (+ video), the 'Revolving Door' campaign and ALTER-EU's new member 'IEMFA'.
2011/12/12
Brussels' revolving door problem: Why the European Commission's response is inadequate (Update: correspondence CEO / Commission)
Since the launch of ALTER-EU's campaign to tackle the 'revolving door' in Brussels on 24 November, Commissioner Šefčovič did not give the impresssion that he takes this important issue very seriously.
2011/12/09

Pages